1. Home
  2. VMD vs AQST Comparison

VMD vs AQST Comparison

Compare VMD & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Viemed Healthcare Inc.

VMD

Viemed Healthcare Inc.

N/A

Current Price

$8.62

Market Cap

351.6M

Sector

N/A

ML Signal

N/A

Logo Aquestive Therapeutics Inc.

AQST

Aquestive Therapeutics Inc.

N/A

Current Price

$3.71

Market Cap

529.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VMD
AQST
Founded
2006
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
351.6M
529.4M
IPO Year
2018
2007

Fundamental Metrics

Financial Performance
Metric
VMD
AQST
Price
$8.62
$3.71
Analyst Decision
Hold
Strong Buy
Analyst Count
2
9
Target Price
★ $12.00
$9.33
AVG Volume (30 Days)
176.9K
★ 2.2M
Earning Date
11-04-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 32.14
N/A
EPS
★ 0.24
N/A
Revenue
★ $270,280,000.00
$67,430,000.00
Revenue This Year
$17.63
$11.13
Revenue Next Year
$11.23
$40.69
P/E Ratio
$37.33
★ N/A
Revenue Growth
★ 20.52
0.77
52 Week Low
$6.31
$2.94
52 Week High
$12.61
$6.74

Technical Indicators

Market Signals
Indicator
VMD
AQST
Relative Strength Index (RSI) 36.19 42.49
Support Level $8.57 $3.59
Resistance Level $10.07 $4.34
Average True Range (ATR) 0.35 0.24
MACD -0.08 0.03
Stochastic Oscillator 5.07 47.41

Price Performance

Historical Comparison
VMD
AQST

About VMD Viemed Healthcare Inc.

Viemed Healthcare Inc is a provider of home medical equipment ("HME") and post-acute healthcare services in the United States, with a focus on respiratory, chronic care, and women's health products and services. The Company's primary service offerings focus on effective in-home treatment, with clinical practitioners providing therapy and counseling to patients in their homes using cutting-edge technology. The company generates the majority of its revenue from medical equipment rental, sales, and supply.

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

Share on Social Networks: